These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16672400)

  • 1. Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.
    Huang SL; Chao A; Hsueh S; Chao FY; Huang CC; Yang JE; Lin CY; Yan CC; Chou HH; Huang KG; Huang HJ; Wu TI; Tseng MJ; Qiu JT; Lin CT; Chang TC; Lai CH
    J Clin Microbiol; 2006 May; 44(5):1733-9. PubMed ID: 16672400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.
    Söderlund-Strand A; Rymark P; Andersson P; Dillner J; Dillner L
    J Clin Microbiol; 2005 Jul; 43(7):3260-6. PubMed ID: 16000445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
    Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
    Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA recovery from Hybrid Capture II samples stored in specimen transport medium with denaturing reagent, for the detection of human papillomavirus by PCR.
    Rabelo-Santos SH; Levi JE; Derchain SF; Sarian LO; Zeferino LC; Messias S; Moraes DL; Campos EA; Syrjänen KJ
    J Virol Methods; 2005 Jun; 126(1-2):197-201. PubMed ID: 15847937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
    Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
    Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR.
    Lin CY; Chao A; Yang YC; Chou HH; Ho CM; Lin RW; Chang TC; Chiou JY; Chao FY; Wang KL; Chien TY; Hsueh S; Huang CC; Chen CJ; Lai CH
    J Clin Virol; 2008 Aug; 42(4):361-7. PubMed ID: 18455959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results.
    Mo LZ; Monnier-Benoit S; Kantelip B; Petitjean A; Riethmuller D; Prétet JL; Mougin C
    J Clin Virol; 2008 Feb; 41(2):104-10. PubMed ID: 18036888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of human papillomavirus DNA in cervical samples: analysis of the new PGMY-PCR compared to the hybrid capture II and MY-PCR assays and a two-step nested PCR assay.
    Giovannelli L; Lama A; Capra G; Giordano V; Aricò P; Ammatuna P
    J Clin Microbiol; 2004 Aug; 42(8):3861-4. PubMed ID: 15297550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.
    J Natl Cancer Inst; 2000 Mar; 92(5):397-402. PubMed ID: 10700419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid Capture II and polymerase chain reaction.
    Riethmuller D; Gay C; Bertrand X; Bettinger D; Schaal JP; Carbillet JP; Lassabe C; Arveux P; Seilles E; Mougin C
    Diagn Mol Pathol; 1999 Sep; 8(3):157-64. PubMed ID: 10565688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.
    van Hamont D; van Ham MA; Bakkers JM; Massuger LF; Melchers WJ
    J Clin Microbiol; 2006 Sep; 44(9):3122-9. PubMed ID: 16954236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
    Layfield LJ; Qureshi MN
    Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.
    Prétet JL; Dalstein V; Monnier-Benoit S; Delpeut S; Mougin C
    J Clin Virol; 2004 Oct; 31(2):140-7. PubMed ID: 15364271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCR study of a series of ASCUS cases HPV-positive by HCII.
    Alameda F; Bellosillo B; Lloveras B; Pairet S; Musset M; Pijuan L; Mariñoso L; Mancebo G; Larrazabal F; Carreras R; Serrano S
    Diagn Cytopathol; 2012 Dec; 40(12):1043-6. PubMed ID: 21656701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.
    Poljak M; Marin IJ; Seme K; Vince A
    J Clin Virol; 2002 Dec; 25 Suppl 3():S89-97. PubMed ID: 12467782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two PCR-based human papillomavirus genotyping methods.
    Castle PE; Porras C; Quint WG; Rodriguez AC; Schiffman M; Gravitt PE; González P; Katki HA; Silva S; Freer E; Van Doorn LJ; Jiménez S; Herrero R; Hildesheim A;
    J Clin Microbiol; 2008 Oct; 46(10):3437-45. PubMed ID: 18716224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid capture II and polymerase chain reaction for identifying HPV infections in samples collected in a new collection medium: a comparison.
    Nonogaki S; Wakamatsu A; Longatto Filho A; Pereira SM; Utagawa ML; Ferreira Alves VA; Di Loreto C; Sakamoto Maeda MY; Lima TP; Roteli-Martins C; Syrjänen K
    Acta Cytol; 2004; 48(4):514-20. PubMed ID: 15296342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections.
    Baleriola C; Millar D; Melki J; Coulston N; Altman P; Rismanto N; Rawlinson W
    J Clin Virol; 2008 May; 42(1):22-6. PubMed ID: 18262463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.